The year 2024 began with a general expectation of greater stability and fewer unknowns. This sentiment has been reflected in a significant improvement in biotech funding, which rose to approximately $23 billion in Q1 2024, the fourth highest quarter on record. As supply chain, credit, and worker shortages ease, new legislation might introduce additional pressures [...] The post ROBO Global Healthcare Technology & Innovation – HTEC: Q2 Index Commentary appeared first on ETF Trends .